Sign in
CompletedNo phase

Exoskeleton Footwear to Improve Walking

Key facts

Who runs it
VA Office of Research and Development
Where
Omaha, United StatesSee the site
Trial code
Status
Completed
People taking part
47 people enrolled
Started
1 Aug 2020
Ended
30 Aug 2026
Type of study
Observational, 2 groups
Treatments tested
  • Exoskeleton footwear
Record updated
2 October 2026

Who can take part

Age
40 years and older
Sex
Women and men
Healthy volunteers
Can take part

The registry criteria, word for word

Show all 11 criteriaShow less

Who can take part

  • Be able to give written, informed consent
  • Have a stable blood pressure regimen, stable lipid regimen, stable diabetes regimen and risk factor control for 6 weeks as determined by a health history questionnaire
  • Be 40 years of age or older; Healthy aged selected to match the population of patients with PAD
  • Demonstrate negative history of chronic claudication or other exercise limitation as determined by a health history questionnaire
  • Meet criteria 1-3 from above
  • Demonstrate positive history of chronic claudication pain
  • Demonstrate exercise-limiting claudication per history and direct observation
  • Have evidence of occlusive disease on ankle/brachial index testing and/or computerized tomographic angiography

Who cannot take part

  • Walking capacity limited by conditions affecting the legs (joint/musculoskeletal, neurologic) and systemic (heart, lung disease) pathology
  • An ankle-brachial index < 0.90 at rest, as measured by the study team; Healthy subjects only
  • Individuals without symptoms but with reduce blood flow (asymptomatic PAD) will be excluded

Where in United States

  • Omaha VA Nebraska-Western Iowa Health Care System, Omaha, NEOmaha, United States

About the trial

What the trial wants to find out

The purpose of this study is to determine the best assistance level of an exoskeleton footwear (EF) that can assist walking for people older than 40 with and without peripheral artery disease (PAD). The test will be performed on two different groups of people for this study that include: 1) people with PAD, and 2) individuals who don't have PAD.

Read full original descriptionShow less

Data will be collected from 50 healthy older individuals and 25 patients with PAD, both groups will be 40 years or older.

Gait biomechanics, muscle oxygenation, and energy cost for seven different walking conditions including normal walking, walking with EF with no assistance, and walking with EF with 5 different levels of assistance will be collected from the healthy older individuals. Additionally, subject-reported outcomes after each walking conditions including perceived comfort and fatigue, rate of perceived exertion and feasibility of the EF will be collected.

Gait biomechanics, muscle oxygenation, energy cost, and patient-reported outcomes will be measured in patients with PAD for four walking conditions including normal walking, walking with EF but no assistance, walking with EF with the best two assistance levels. Subjects will be allowed to acclimate to the EF prior to recording data. All patients with PAD will participate in feasibility interviews that will assess acceptability, demand, implementation, and practicality.

All subjects will be asked to fill out questionnaires that assess quality of life, physical function, and the ability to complete activities of daily living.

The 2 groups in the trial

  • Older healthy

    Individuals over 40 years of age

    Treatment: Exoskeleton footwear

  • Peripheral artery disease

    Individuals over 40 years of age with peripheral artery disease.

    Treatment: Exoskeleton footwear

Data and sources

Registry record
Listed on ClinicalTrials.gov.How to verify a trial in the registry
Official title
Exoskeleton Footwear to Improve Walking Performance and Subject-reported Preference
Record updated
2 October 2026